almitrine has been researched along with almitrine, raubasine drug combination in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C | 1 |
| Guez, D | 1 |
| Labrid, C | 1 |
| Blondin, P; Bordes, LR; Soubeyrand, L | 1 |
| Sebban, C | 1 |
| Mémin, Y | 2 |
| Anderer, P; Grünberger, J; Linzmayer, L; Saletu, B | 1 |
| Devissaguet, M | 1 |
| Delorme, P | 2 |
| Actis, H; Dellazuana, O; Duhault, J; Roman, F | 1 |
| Berthaux, P; Sebban, C | 1 |
| Berthaux, P; Laforestrie, R | 1 |
| Chan, P | 1 |
| Li, SW | 1 |
| Benzi, G | 1 |
| Allain, H; Bentué-Ferrer, D | 1 |
| Li, J; Li, S; Long, J; Ma, Z; Xu, Z; Zhang, Z | 1 |
| Li, ZH; Shi, YM; Xu, WJ; Zou, YH | 1 |
| Hao, Z; Liu, GJ; Liu, M; Teng, J; Wu, B; Wu, T; Yang, W | 1 |
6 review(s) available for almitrine and almitrine, raubasine drug combination
| Article | Year |
|---|---|
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine | 1990 |
[Experimental models in cerebral ischemia: application to the study of duxil].
Topics: Almitrine; Animals; Brain Ischemia; Cats; Cerebral Arteries; Disease Models, Animal; Dogs; Drug Combinations; Gerbillinae; Humans; Piperazines; Rabbits; Rats; Yohimbine | 1988 |
Pathophysiology of postischemic hypoxia and cerebral protection: implications of the almitrine and raubasine combination.
Topics: Almitrine; Animals; Brain Ischemia; Drug Combinations; Hypoxia, Brain; Ischemic Attack, Transient; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Treatment Outcome; Yohimbine | 1995 |
Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
Topics: Almitrine; Blood Glucose; Brain; Cerebrovascular Circulation; Drug Combinations; Energy Metabolism; Humans; Neuroprotective Agents; Oxygen; Partial Pressure; Yohimbine | 1998 |
Clinical efficacy of almitrine-raubasine. An overview.
Topics: Aged; Aging; Almitrine; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Humans; Ischemia; Neuroprotective Agents; Retinal Vessels; Treatment Outcome; Yohimbine | 1998 |
Almitrine-Raubasine combination for dementia.
Topics: Aged; Almitrine; Dementia; Drug Combinations; Humans; Middle Aged; Neuroprotective Agents; Yohimbine | 2011 |
7 trial(s) available for almitrine and almitrine, raubasine drug combination
| Article | Year |
|---|---|
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine | 1990 |
Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
Topics: Aged; Almitrine; Arousal; Cognition; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Electroencephalography; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Piperazines; Psychomotor Performance; Random Allocation; Yohimbine | 1988 |
[Comparison of the effects of almitrine, raubasine and 5023 SE on arterial oxygen desaturation during exercise].
Topics: Almitrine; Arteries; Drug Combinations; Humans; Middle Aged; Oxygen; Physical Exertion; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1983 |
[Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
Topics: Aged; Almitrine; Brain Diseases; Dementia; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen; Partial Pressure; Piperazines; Time Factors; Yohimbine | 1983 |
[Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
Topics: Aged; Almitrine; Clinical Trials as Topic; Dementia; Double-Blind Method; Drug Combinations; Humans; Mental Processes; Piperazines; Psychomotor Performance; Reaction Time; Yohimbine | 1983 |
Assessment of the therapeutic activity of a combination of almitrine and raubasine on functional rehabilitation following ischaemic stroke.
Topics: Aged; Almitrine; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Recovery of Function; Stroke; Stroke Rehabilitation; Treatment Outcome; Yohimbine | 2004 |
[Clinical research of effect of Yishen Yangnao capsule on vascular dementia].
Topics: Activities of Daily Living; Aged; Almitrine; Capsules; Dementia, Vascular; Drug Combinations; Drugs, Chinese Herbal; Event-Related Potentials, P300; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Neuroprotective Agents; Phytotherapy; Treatment Outcome; Yohimbine | 2007 |
11 other study(ies) available for almitrine and almitrine, raubasine drug combination
| Article | Year |
|---|---|
[Evaluation of acute and chronic cerebral ischemia in man by positron and single photon emission tomography: application to the study of duxil].
Topics: Acute Disease; Aged; Almitrine; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Drug Combinations; Female; Humans; Male; Middle Aged; Oxygen Consumption; Piperazines; Tomography, Emission-Computed; Yohimbine | 1988 |
[First Forum on Updates on Cerebral Ischemia Pathology. Seville, 1-4 October 1987. Proceedings].
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Piperazines; Yohimbine | 1988 |
[Evaluation of the activity of duxil in the endocochlear hypoacusis of ischemic origin].
Topics: Adult; Aged; Almitrine; Audiometry; Cochlea; Drug Combinations; Evoked Potentials, Auditory; Female; Hearing Disorders; Humans; Ischemia; Labyrinth Diseases; Male; Middle Aged; Piperazines; Yohimbine | 1988 |
[Exploration of the effects of duxil on the central nervous system by quantified electroencephalography].
Topics: Aged; Aging; Almitrine; Animals; Brain; Drug Combinations; Electroencephalography; Humans; Piperazines; Rats; Yohimbine | 1988 |
[Evaluation of the therapeutic effect of duxil in chronic cerebral insufficiency. Analysis of 4636 patients at cerebrovascular risk].
Topics: Aged; Almitrine; Attention; Brain Ischemia; Chronic Disease; Drug Combinations; Humans; Hypoxia, Brain; Memory; Middle Aged; Piperazines; Risk Factors; Yohimbine | 1988 |
[Pharmacological approach to a treatment of senescence and cerebrovascular deficiencies related to hypoxia. Application to 5023 SE].
Topics: Aging; Almitrine; Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Dogs; Drug Combinations; Glucose; Humans; Hypoxia, Brain; Neurons; Oxygen Consumption; Piperazines; Rabbits; Rats; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the cerebral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Microscopy, Electron; Piperazines; Rabbits; Telencephalon; Time Factors; Yohimbine | 1983 |
[Ultrastructural study of acute ischemia at the peripheral level. Effects of 5023 SE].
Topics: Acute Disease; Almitrine; Animals; Brain Ischemia; Carotid Arteries; Disease Models, Animal; Drug Combinations; Endothelium; Microscopy, Electron; Piperazines; Rabbits; Yohimbine | 1983 |
[Effects of 5023 SE on experimental cerebral ischemia in gerbils].
Topics: Almitrine; Animals; Brain Ischemia; Disease Models, Animal; Drug Combinations; Gerbillinae; Piperazines; Time Factors; Yohimbine | 1983 |
Cerebral ischemia: from pharmacology to modern techniques and clinical implications. Value of almitrine-raubasin (Duxil Duxaril). International symposium, Hangzhou, People's Republic of China, May 14, 1994.
Topics: Almitrine; Brain Ischemia; Drug Combinations; Humans; Neuroprotective Agents; Piperazines; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
Stroke and functional rehabilitation: the Chinese experience.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cerebrovascular Disorders; China; Drug Combinations; Female; Humans; Incidence; Male; Middle Aged; Neuroprotective Agents; Prevalence; Yohimbine | 1998 |